Analysis of 36 patients with type B aortic intramural hematoma: clinical presentations, treatments and outcomes in a single center

Fei Mei,Jinfeng Xie,Chao Yang,Xianghai Kong,Bi Jin,Yiqing Li
DOI: https://doi.org/10.3760/cma.j.issn.1008-1372.2014.03.011
2014-01-01
Abstract:Objective To review the clinical manifestation,diagnosis method,misdiagnosis,risk factors,treatments and prognosis of Stanford B aortic intramural hematoma (IMHB).Methods All of the Stanford B aortic IMHB patients admitted in Wuhan Union hospital from January 2008 to December 2013 were analyzed.The clinical manifestation,diagnosis method,misdiagnosis,managements and prognosis were studied.Furthermore,the effect and long-term survival of different therapies were compared,including medical treatment and endovascular repair.The statistics was performed with SPSS 16.0.Results There were 36 B aortic IMHB patients,and the percent of male patients was 72.22%.The mean age of IMHB was 60.19 ± 11.12.Most patients complained of acute chest and back pain,accompanied with hypertension.Twenty-eight patients (77.78%) received medication therapy,among them,there were 5 patients died of aortic rupture; eight patients (22.22%) received endovascular surgery,one died of cerebral hemorrhage (12.5%).No difference was found between medication therapy and endovascular surgery (17.86% vs 12.5%,P >0.05).Conclusions For simple type B aortic IMHB patients,medication therapy and a dynamic monitoring of full aortic CT angiography was recommended,and for pejorative patients the endovascular treatment should be taken actively.
What problem does this paper attempt to address?